🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G1933S101 (prev. 29382F202 )
- Market Cap
- Small Cap
- Previous Symbol
- ENMD (changed 6/16/2014)
- Previous Name
- EntreMed, Inc.
Business: CASI Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition ,development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company employs a global drug-development strategy that leverages our expertise and resources in North America and China. By conducting trials under both North American and Chinese regulatory pathways, The Company intends to reach clinical efficacy inflection points with drug candidates at greater cost-efficiencies.
Notes: June 30, 2010 EntreMed, Inc. (Nasdaq: ENMD), today announced that it has filed a certificate of amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-11 reverse stock split that will become effective with the open of trading on July 1, 2010.
Company Contact
- CEO
- Wei-Wu He
- CFO
- Larry (Wei) Zhang
- Headquarters
- 9620 Medical Center Drive, Suite 300, Rockville, MD 20850
- Phone
- 240-864-2600
- Fax
- 240-864-2601
- Investor Relations
- Jennifer Porcelli, Solebury Trout · 646-378-2962 · jporcelli@troutgroup.com